The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cardiovascular diseases after Hodgkin lymphoma treatment: 35-year disease risk and sequence of events.
Frederika A. van Nimwegen
No relevant relationships to disclose
Michael Schaapveld
No relevant relationships to disclose
Cecile P.M. Janus
No relevant relationships to disclose
Augustinus D.G. Krol
No relevant relationships to disclose
John M.M. Raemaekers
No relevant relationships to disclose
Eefke J. Clevers-Petersen
No relevant relationships to disclose
Berthe M.P. Aleman
No relevant relationships to disclose
Flora E. van Leeuwen
No relevant relationships to disclose